Software
Segment Quantitative Cardiac MRI Software
![](https://scintica.com/wp-content/uploads/2022/01/left-ventricular-RV.gif)
The Segment application is a comprehensive software solution for quantitative cardiac MR image analysis; the software has been specifically designed for use in preclinical research and will work with images acquired on our M-Series MRI systems
Imalytics Preclinical Software for Biomedical Image Analysis
![](https://scintica.com/wp-content/uploads/2023/08/Signal_Quantification_Imalytics.jpg)
Imalytics Preclinical is a software for fast interactive segmentation, reconstruction, 3D visualization, and analysis of biomedical image data sets with a user-friendly interface. It supports 3D, 4D, and 5D image data from any modality if the file format is supported. It has been used to analyze (multimodal) data sets from CT, PET, SPECT, MRI, US, FLT, and BLT.
Invicro’s Quantitative Image Analysis Platform
![](https://scintica.com/wp-content/uploads/2021/05/invicro-vivoquant_Computer-1-e1621434786215.png)
VivoQuant is Invicro’s quantitative image analysis platform. As a vendor neutral software product, VivoQuant streamlines image analysis research studies across all phases of drug discovery and development, supporting multi-modality and multi-species image processing applications.
Request a Quote
Our group of experts will be in touch with you to find the best solution that suits your research work.
In max 24 hours you will get your quote in your inbox.
Articles, Webinars & Publications
Publication Highlight: Feasibility of in vitro calcification plaque disruption using ultrasound-induced microbubble inertial cavitation
System Used:DELab µCT-100 M-SeriesChing-Hsiang Fan, Chieh-Yu Tsai, Chun-Yen Lai, Ya-Fu Liou, Jen-Kuang Lee,
Publication Highlight : Inhalable siRNA Nanoparticles for Enhanced Tumor-Targeting Treatment of KRAS-Mutant Non-Small-Cell Lung Cancer
System Used: IVIM System M-Series Guolin Zhao, William Ho, Jinxian Chu, Xiaojian Xiong,
(June 12, 2024) Webinar: Development of PET theranostics targeting the molecular chaperones eHsp90 and HtpG for cancer and infectious disease
(June 12, 2024) Webinar: Development of PET theranostics targeting the molecular chaperones eHsp90